Reversibility of cirrhosis in chronic hepatitis B
Open Access
- 30 April 2004
- journal article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 2 (4), 344-347
- https://doi.org/10.1016/s1542-3565(04)00066-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase InhibitionPublished by Elsevier BV ,2002
- Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis BJournal of Hepatology, 2001
- Interferon α Treatment and Retreatment of Hepatitis B e Antigen-Negative Chronic Hepatitis BGastroenterology, 2001
- Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factorsGut, 2001
- Impact of Interferon Alfa-2b and Ribavirin on Progression of Liver Fibrosis in Patients With Chronic Hepatitis CHepatology, 2000
- Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic viewGastroenterology, 1999
- Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.JCI Insight, 1998
- Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosisHepatology, 1996
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993